2950 Results

People

  1. Scheinberg
    Scheinberg
  2. Sadelain
    Sadelain
  3. Lesokhin
    Lesokhin
  4. Landgren
    Landgren
  5. Brentjens
    Brentjens
  6. Chiosis
    Chiosis
  7. Giralt
    Giralt
  8. Korde
    Korde
  9. Mailankody
    Mailankody
  10. Hassoun
    Hassoun

Groups

  1. Center for Hematologic Malignancies (2950)
  2. Hematologic Malignancies Research (2950)
  3. GSK Faculty (2412)
  4. Department of Medicine (2277)
  5. Hematologic Malignancies, Division of (2078)
  6. Sloan Kettering Institute Faculty (2026)
  7. Molecular Pharmacology and Chemistry Program Faculty (1617)
  8. Tow Center for Developmental Oncology (TCDO) (1043)
  9. Sloan Kettering Institute Postdocs (1029)
  10. Adult Leukemia (871)
  1. "Hematologic Malignancies Research"
Formats
  1. Journal Article (1521)
  2. Meeting Abstract (1232)
  3. Review (76)
  4. Editorial (34)
  5. Book Section (32)
  6. Research Letter (25)
  7. Conference Paper (15)
  8. Correspondence (7)
  9. Guidelines (4)
  10. Miscellaneous (3)
  11. Book Whole (1)
Groups
  1. Center for Hematologic Malignancies (2950)
  2. Hematologic Malignancies Research (2950)
  3. GSK Faculty (2412)
  4. Department of Medicine (2277)
  5. Hematologic Malignancies, Division of (2078)
  6. Sloan Kettering Institute Faculty (2026)

More Groups

People
  1. Michel Sadelain (582)
  2. David Scheinberg (499)
  3. Alexander Lesokhin (363)
  4. Carl Landgren (336)
  5. Renier Brentjens (286)
  6. Gabriela Chiosis (279)

More People

Years
  1. 2025 (32)
  2. 2024 (108)
  3. 2023 (175)
  4. 2022 (126)
  5. 2021 (154)
  6. 2020 (173)

More Years

Publications
  1. Blood (636)
  2. Cancer Research (117)
  3. Journal of Clinical Oncology (108)
  4. Clinical Lymphoma, Myeloma and Leukemia (84)
  5. Biology of Blood and Marrow Transplantation (80)
  6. Molecular Therapy (68)

More Publications

Publishers
  1. American Society of Hematology (674)
  2. Nature Publishing Group (367)
  3. Elsevier Inc. (290)
  4. American Association for Cancer Research (245)
  5. Cell Press (116)
  6. American Society of Clinical Oncology (112)

More Publishers

Results (2950)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • PD-L1 ligation enhances NK cell anti-tumor function by inducing a metabolic shift
    Meeting Abstract

    Srpan, K.; Lupo, K.; Hsu, K.
    European Journal of Immunology (2024)

    Fulltext@MSK | Save
  • BPDCN MYB fusions regulate cell cycle genes, impair differentiation, and induce myeloid–dendritic cell leukemia
    Journal Article

    Booth, C. A. G.; Bouyssou, J. M.; Togami, K.; Armand, O.; Rivas, H. G.; Yan, K.; Rice, S.; Cheng, S.; Lachtara, E. M.; Bourquin, J. P.; more...
    JCI Insight (2024)

    Fulltext@MSK | Save
  • Down syndrome frontal cortex layer III and layer V pyramidal neurons exhibit lamina specific degeneration in aged individuals
    Journal Article

    Alldred, M. J.; Ibrahim, K. W.; Pidikiti, H.; Chiosis, G.; Mufson, E. J.; Stutzmann, G. E.; Ginsberg, S. D.
    Acta Neuropathologica Communications (2024)

    Fulltext@MSK | Save
  • CAR T-cell-derived TNF drives cytokine release syndrome and enhances M1 macrophage differentiation
    Meeting Abstract

    Lindenbergh, P. L.; Giavridis, T.; Vivier, O.; Lopez, M.; Dobrin, A.; Sadelain, M.
    Molecular Therapy (2024)

    Fulltext@MSK | Save
  • Integrating Chemical Tools to Interrogate Protein Methylation in Nuclei
    Meeting Abstract

    Luo, M.
    Journal of Biological Chemistry (2024)

    Fulltext@MSK | Save
  • Identifying and exploiting cell-state dependent metabolic networks
    Meeting Abstract

    Finley, L.
    Journal of Biological Chemistry (2024)

    Fulltext@MSK | Save
  • MagnetisMM-30: A phase 1B, open-label study of elranatamab in combination with iberdomide in patients with relapsed or refractory multiple myeloma (RRMM)
    Meeting Abstract

    Lesokhin, A.; Raza, M.; Acosta, J.; Mueller, P. Y.; O'Connell, A.; Yver, A.; Lou, C.; Finn, G.
    Clinical Lymphoma, Myeloma and Leukemia (2024)

    Fulltext@MSK | Save
  • Defining the rates of cytokine release syndrome associated with Talquetamab step-up doses
    Meeting Abstract

    Hamadeh, I.; Shekarkhand, T.; Rueda, C.; Firestone, R.; Wang, A.; Korde, N.; Hultcrantz, M.; Lesokhin, A.; Mailankody, S.; Hassoun, H.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2024)

    Fulltext@MSK | Save
  • Whole genome sequencing reveals lower APOBEC-mutational activity in multiple myeloma patients with African ancestry compared with those of non-African ancestry
    Meeting Abstract

    Maclachlan, K.; Papadimitriou, M.; Blaney, P.; McPherson, A.; Chu, T.; Diamond, B.; Ziccheddu, B.; Shekarkhand, T.; Poos, A.; Brown, E.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2024)

    Fulltext@MSK | Save
  • Comprehensive genomic sequencing predicts sub-optimal response to bispecific antibodies (BsAb) and chimeric antigen receptor T cells (CAR-T) in multiple myeloma (MM)
    Meeting Abstract

    Maclachlan, K.; Shekarkhand, T.; Farzana, T.; Costa, B.; Firestone, R.; Jurgens, E.; Rajeeve, S.; Hashmi, H.; Hassoun, H.; Shah, U.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2024)

    Fulltext@MSK | Save